Yes, American Diabetes Association Scientific Sessions is the biggest one in the USA & a lot of International attendees & major clinical trials announced at this conference. There are thousands of posters, abstracts & presentations split across the different areas of diabetes care & associated complications of diabetes including cardio-renal which is our interest here with PromarkerD & how this is relevant with new treatments for DKD & CVD.
We await Ph 2 of Janssen Study, but PromarkerD has already been validated on Stage 1 Janssen trial & prior clinical studies.
Abstracts have to be in months in advance for acceptance to conferences, & even late breaking abstracts in advance, but often aren’t announced until just before a conference starts. Why I’m not concerned about clinical data not being presented here, because it’s very possible the deadline was missed if Janssen/PIQ co-presenting again like they did at ADA 2019 with Ph1 of the Study.
Of course the Economic Health Data Modelling presented at ADA is just mind blowing the enormity of it, but I think if people were doing their homework over the last few years, that should come as no surprise.
PIQ Price at posting:
92.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)